Julia Bonavitacola

A presentation at the Society for Pediatric Dermatology Annual Conference discussed how to use generative artificial intelligence (AI) to improve processes while working in the dermatology space.

The Society for Pediatric Dermatology (SPD) Annual Meeting featured a new debates segment where experts in the field discussed preferred strategies for the treatment of pediatric skin conditions.

Doug Fulling, MA, discussed how introducing payers into clinical research earlier could help manufacturers, payers, and patients.

Community support and molecular epidemiological approaches could help HIV prevention in Australia.

Twice-daily application of 1.5% ruxolitinib cream was found to be effective in children and adolescents with atopic dermatitis and vitiligo.

Jessilin Quint, OD, MBA, FAAO, from Smart Eye Care, and Rebecca Petris, co-founder of the Dry Eye Foundation, spoke about their biggest takeaways from a recent dry eye survey conducted by The Harris Poll on behalf of Bausch + Lomb.

A nomogram model that included log odd of positive lymph node was effective in predicting prognosis of early-onset colorectal cancer (EOCRC).

Interventions for female sex workers in Tanzania could help in reducing the incidence of HIV in this population.

The annual meeting will take place in Toronto July 11-15, 2024.

Patients with age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion can use faricimab-svoa as a prefilled syringe (PFS).

Adult patients with dry eye revealed their different challenges and experiences when living with the disease.

Men who have sex with men who are living with HIV were found to have a significant burden of both hepatitis B and C infections.

Between 2016 and 2021, the percentage of screening colonoscopies performed by a family physician saw a decrease across the country.

Patients with dry eye disease can be distinguished from patients with healthy eyes using a new artificial intelligence tool.

In a recent study, novel genetic associations between obesity, colorectal cancer (CRC), and irritable bowel disease (IBD) were identified.

Jared Baeten, MD, PhD, discusses when lenacapavir could be available for the prevention of HIV, as well as other trials in the PURPOSE program.

Test your knowledge of the June 2024 issue of AJMC with this quick quiz!

Jared Baeten, MD, PhD, discusses the significance of the PURPOSE 1 trial results, which found that lenacapavir for pre-exposure prophylaxis resulted in no new infections of HIV.

Patients who used adjuvant chemotherapy were found to have a higher survival rate after achieving complete pathological response.

Supportive care interventions could help address concerns and help patients during the recurrence of ovarian cancer.

Incidence of postoperative endophthalmitis was low when patients were treated with either 1% povidone iodine disinfection with intracameral antibiotics or 5% povidone iodine with antibiotics.

Peer-based health advocacy for patients living with HIV can be received differently and affect HIV protective behavior based on gender dynamics and relationship type.

Adult patients who have KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC) can use adagrasib as a supplemental treatment.

Both preoperative pan-immune inflammation value (PIV) and monocyte to high-density lipoprotein ratio (MHR) were found to be independent risk factors when it came to the prognosis for colorectal cancer (CRC).

Legislation that could change the 340B program should be done so with caution, as the federal program acts as a boon to care for patients with HIV, experts argue.

Older adults who had colorectal surgery were found to have reduced postoperative complications if they started the Geriatric Oncology Service.

A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence.

A recent review found that benzene exposure due to work may be linked to the development of colorectal cancer.

Neurotrophic tyrosine receptor kinase (NTRK)–positive locally advanced or metastatic solid tumors can now be treated with the first FDA-approved treatment option.

The SLEEP 2024 Annual Meeting featured talks on numerous topics throughout the 5-day meeting, including sleep inequities, narcolepsy, and mental health’s association with sleep.